A measure of cognitions specific to seasonal depression: Development and validation of the Seasonal Beliefs Questionnaire.


Journal

Psychological assessment
ISSN: 1939-134X
Titre abrégé: Psychol Assess
Pays: United States
ID NLM: 8915253

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 29 3 2019
medline: 5 11 2019
entrez: 29 3 2019
Statut: ppublish

Résumé

We introduce the Seasonal Beliefs Questionnaire (SBQ), a self-report inventory of maladaptive thoughts about the seasons, light availability, and weather conditions, proposed to constitute a unique cognitive vulnerability to winter seasonal affective disorder (SAD; Rohan, Roecklein, & Haaga, 2009). Potential items were derived from a qualitative analysis of self-reported thoughts during SAD-tailored cognitive-behavioral therapy (CBT-SAD) and subsequently refined based on qualitative feedback from 48 SAD patients. In the psychometric study (N = 536 college students), exploratory and confirmatory factor analyses pruned the items to a 26-item scale with a 5-factor solution, demonstrating good internal consistency, convergent and divergent validity, and 2-week test-retest reliability. In a known groups comparison, the SBQ discriminated SAD patients (n = 86) from both nonseasonal major depressive disorder (MDD) patients (n = 30) and healthy controls (n = 110), whereas a generic measure of depressogenic cognitive vulnerability (the Dysfunctional Attitudes Scale [DAS]) discriminated MDD patients from the other groups. In a randomized clinical trial comparing CBT-SAD with light therapy (N = 177), SBQ scores improved at twice the rate in CBT-SAD than in light therapy. Greater change in SBQ scores during CBT-SAD, but not during light therapy, was associated with a lower risk of depression recurrence 2 winters later. In contrast, DAS scores improved comparably during CBT-SAD and light therapy, and DAS change was unrelated to recurrence following either treatment. These results support using the SBQ as a brief assessment tool for a SAD-specific cognitive vulnerability and as a treatment target in CBT-SAD. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Identifiants

pubmed: 30920245
pii: 2019-16228-001
doi: 10.1037/pas0000715
pmc: PMC7988399
mid: NIHMS1673137
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

925-938

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH078982
Pays : United States
Organisme : National Institute of Mental Health

Références

Can J Psychiatry. 1994 Sep;39(7):387-90
pubmed: 7987780
J Affect Disord. 1998 Jul;50(1):59-64
pubmed: 9716282
J Psychother Pract Res. 2001 Winter;10(1):8-13
pubmed: 11121002
Psychopathology. 2003 May-Jun;36(3):160-7
pubmed: 12845287
Aust N Z J Psychiatry. 1999 Jun;33(3):407-15
pubmed: 10442798
Arch Gen Psychiatry. 1984 Jan;41(1):72-80
pubmed: 6581756
Trials. 2013 Mar 21;14:82
pubmed: 23514124
Br J Psychiatry. 1990 Jan;156:73-8
pubmed: 2404539
Psychiatry Res. 2010 Jan 30;175(1-2):82-8
pubmed: 19969377
J Consult Clin Psychol. 2003 Feb;71(1):22-30
pubmed: 12602422
Am J Psychiatry. 1998 Mar;155(3):428-30
pubmed: 9501759
J Affect Disord. 1996 Dec 16;41(3):193-9
pubmed: 8988451
J Consult Clin Psychol. 1990 Jun;58(3):352-9
pubmed: 2195085
Am J Psychiatry. 2015 Sep 1;172(9):862-9
pubmed: 25859764
Am J Psychiatry. 2016 Mar 1;173(3):244-51
pubmed: 26539881
Behav Ther. 2009 Sep;40(3):225-38
pubmed: 19647524
J Consult Clin Psychol. 2009 Dec;77(6):1078-88
pubmed: 19968384
J Affect Disord. 1997 Feb;42(2-3):113-6
pubmed: 9105952
Aust N Z J Psychiatry. 1999 Feb;33(1):70-6
pubmed: 10197887
Behav Res Ther. 2006 Aug;44(8):1159-64
pubmed: 16290816
J Consult Clin Psychol. 1990 Dec;58(6):862-9
pubmed: 2292637
Cognit Ther Res. 2008 Aug 1;32(4):
pubmed: 24353355
J Behav Ther Exp Psychiatry. 2003 Mar;34(1):73-85
pubmed: 12763394
Am J Psychiatry. 2004 Dec;161(12):2163-77
pubmed: 15569884
Arch Gen Psychiatry. 1984 Jan;41(1):45-51
pubmed: 6691784
J Consult Clin Psychol. 2007 Jun;75(3):489-500
pubmed: 17563165
J Abnorm Psychol. 1983 Feb;92(1):107-9
pubmed: 6833629
J Affect Disord. 2011 Sep;133(1-2):311-9
pubmed: 21600661
J Affect Disord. 2006 Jun;92(2-3):231-41
pubmed: 16542734
J Youth Adolesc. 1991 Apr;20(2):149-66
pubmed: 24265004
J Abnorm Psychol. 2002 May;111(2):350-6
pubmed: 12003456
J Affect Disord. 2004 Jun;80(2-3):273-83
pubmed: 15207942

Auteurs

Kelly J Rohan (KJ)

Department of Psychological Science.

Jonah Meyerhoff (J)

Department of Psychological Science.

Sheau-Yan Ho (SY)

Department of Psychological Science.

Kathryn A Roecklein (KA)

Department of Psychology, University of Pittsburgh.

Yael I Nillni (YI)

National Center for PTSD, Women's Health Sciences Division, Veterans Affairs Boston Healthcare System.

Joel J Hillhouse (JJ)

Department of Community and Behavioral Health, East Tennessee State University.

Michael J DeSarno (MJ)

Medical Biostatistics Unit, University of Vermont College of Medicine.

Pamela M Vacek (PM)

Medical Biostatistics Unit, University of Vermont College of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH